|  | Final analysis set (N = 486) | ||
---|---|---|---|---|
 |  | LS Mean | 95 % CI | P value |
Visit | 6 months | 4.04 | 1.64–6.43 | – |
 | 12 months | 7.10 | 4.57–9.63 | – |
 | 18 months | 6.54 | 3.84–9.25 | – |
 | 24 months | 8.51 | 5.75–11.27 | – |
 | 6–12 months | −3.06 | −4.06 to −2.06 | <.0001 |
 | 6–18 months | −2.50 | −3.83 to −1.17 | .0002 |
 | 6–24 months | −4.48 | −5.96 to −2.99 | <.0001 |
 | 12–18 months | 0.56 | −0.59 to 1.70 | .3405 |
 | 12–24 months | −1.41 | −2.78 to −0.05 | .0422 |
 | 18–24 months | −1.97 | −2.92 to −1.02 | <.0001 |
Prior chemotherapies | Yes | 10.99 | 8.20–13.77 | – |
 | No | 2.11 | −0.69 to 4.90 | – |
 | Yes–No | 8.88 | 6.36–11.40 | <.0001 |
Age group | >60 years | 8.04 | 5.04–11.05 | – |
 | ≤60 years | 5.05 | 2.44–7.66 | – |
 | >60 to ≤60 years | 2.99 | 0.37–5.61 | .0256 |
Mastectomy | Yes | 7.63 | 5.88–9.38 | – |
 | No | 5.46 | 0.90–10.03 | – |
 | Yes–No | 2.17 | −2.63 to 6.97 | .3752 |
Axillary lymph-node dissection | Yes | 4.77 | 2.00–7.55 | – |
 | No | 8.32 | 5.22–11.43 | – |
 | Yes–No | −3.55 | −6.68 to −0.41 | .0268 |